HoldCo Bros are back! @NikonomicsPodcast and I break down why print shops, despite being capex heavy and often ignored, are ...

Company launches multi-channel promotional campaign to drive market adoption U.S. losartan market totals $256M annually with 71M prescriptions, creating a significant opportunity for Arbli™ as the ...

Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial ...

Once the individual policy has been issued, the insurer cannot deny renewal based on the health of the insured or his family ...

The Fairness Act has rolled back old rules that reduced benefits for certain public workers and their spouses.

Morgan Geekie hustled to a loose puck behind the net, collected it and slipped it inside the left post with 4.5 seconds left ...

It’s that time again, open enrollment season. Starting November 1, millions of Americans will have the chance to review, ...

The stock makes the Nasdaq top gainers list today on news of Commercial Sales and Fulfillment of First Orders for Arbli. The stock is trading at $1.3200, +0.7485, gaining over 129% on volume of over ...

Scienture (SCNX) announced the start of commercial sales and fulfillment of the first customer orders for Arbli Oral Suspension, 10 mg/mL, marking ...

The recipients included historians, musicians, journalists, medical professionals, and a Druze spiritual leader. Nine people ...

With companies needing new talent to fill some 35,000 vacant positions in industry and high-tech, government officials say ...

Investing.com -- Scienture Holdings Inc (NASDAQ:SCNX) stock surged 61.4% after the company announced it has begun commercial sales and fulfillment of the first customer orders for Arbli™, its ...